1. Bashford, E. F., 1913, The constancy and variability of tumor cells during propagation, in: Transactions of the International Congress of Medicine, London, Section III, Part 2, p. 59.
2. Carey, T. E., Takahashi, T., Resnick, L. A., Oettgen, H. F., and Old, L. J., 1976, Cell surface antigens of human malignant melanoma: Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells, Proc. Natl. Acad. Sci. USA 73: 3278–3282.
3. Chiorrazzi, N., Wasserman, R. L., and Kunkel, H. G., 1982, Use of Epstein—Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas, J. Exp. Med. 156: 930–935.
4. Cote, R. J., Morrissey, D. M., Houghton, A. N., Beattie, E. J., Oettgen, H. F., and Old, L. J., 1983, Generation of human monoclonal antibodies reactive with cellular antigens, Proc. Natl. Acad. Sci. USA 80: 2026–2030.
5. Cote, R. J., Houghton, A. N., Cordon-Cardo, C., Thomson, T. M., Morrissey, D. M., Oettgen, H. F., and Old, L. J., 1984, Immune response of cancer patients: Analysis with human monoclonal antibodies, Fed. Proc. 43: 1663 (abstract 1441).